Seroprevalence of IgG Antibodies to SARS-CoV-2 (COVID-19) in Primary Health Care Workers and Their Household Contacts

NACompletedINTERVENTIONAL
Enrollment

2,817

Participants

Timeline

Start Date

May 10, 2021

Primary Completion Date

October 12, 2021

Study Completion Date

October 12, 2021

Conditions
Covid19
Interventions
DIAGNOSTIC_TEST

Serological test for the detection of IgG anti-SARS-CoV-2

Self-sampling dried-blood spot (DBS) kits will be send to each participant including material (a DBS card, lancets, pad), detailed printed instructionson how to perform thetest, and a self-addressed stamped padded envelope to be returned with the card to the centralized biobank (CEPH Biobank, Paris, France). Tubes will be sent sent to the virology laboratory (Unité des virus Émergents, Marseille, France) for serological analysis.

Trial Locations (1)

75012

Institut Pierre Louis Epidemiologie Et Sante Publique, Paris

All Listed Sponsors
lead

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV